Plerixafor is an immunostimulant used to mobilize hematopoietic stem cells in
cancer patients ... ball-and-stick model.png. Clinical data. Trade names, Mozobil.
Official site from Genzyme Corporation. Contains consumer and prescribing
Learn more about Mozobil (plerixafor injection).The Mozobil Professional website
is designed to help healthcare professionals care for their patients with ...
Your doctor will provide you with detailed instructions about the administration of
Mozobil (plerixafor injection) for your stem cell mobilization.
Aug 27, 2015 ... Find a comprehensive guide to possible side effects including common and rare
side effects when taking Mozobil (Plerixafor Injection) for ...
MOZOBIL. MOZOBIL (plerixafor injection), Solution for Subcutaneous use ...
Initiate Mozobil treatment after the patient has received G-CSF once daily for 4
Mozobil 20 mg/ml solution for injection. 2. QUALITATIVE AND QUANTITATIVE
COMPOSITION. One ml of solution contains 20 mg plerixafor. Each vial contains
Mozobil, a hematopoietic stem cell mobilizer, is indicated in combination with
granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem
Mozobil (plerixafor injection): For the treatment of non-Hodgkin's lymphoma and
multiple myeloma. New approved drug details including side effects, uses and ...
Dec 15, 2008 ... “Mozobil is an important advancement in the treatment of patients with certain
types of cancer who require a stem cell transplant,” said John F.